News | EP Lab
Boston Scientific Corp. has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and Mini implantable cardioverter defibrillator (ICD) and the X4 cardiac resynchronization therapy defibrillator (CRT-D) systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.
October 30, 2015
News | Stents Bioresorbable
October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable ...
October 30, 2015
News | Hemodynamic Support Devices
October 30, 2015 — Results from the SHIELD I (Coronary InterventionS in HIgh-Risk PatiEnts Using a Novel Percutaneous ...
October 30, 2015Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Videos | Intravascular Imaging
Ziad Ali, M.D., associate director of translational medicine, Columbia University Medical Center / New York-Presbyterian ...
October 30, 2015
Videos | Radial Access
Sunil Rao, M.D., associate professor of medicine and a member in the Duke University Clinical Research Institute, a ...
October 30, 2015
Videos | Balloon Catheter
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford ...
October 30, 2015Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Videos | Stents Drug Eluting
Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide ...
October 30, 2015
Videos | Stents Bioresorbable
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
October 30, 2015
Videos | Heart Failure
Manesh Patel, M.D., associate professor of medicine, and director of interventional cardiology and the cath labs at Duke ...
October 30, 2015Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stroke
Results from a new survey from the American Heart Association/American Stroke Association found that only half of healthcare professionals consider themselves adequately equipped with information about cryptogenic stroke, a stroke in which the underlying cause is still unknown after extensive testing. Depending on their specialty, 51-70 percent of physicians admit being uncertain about the best approaches to finding the underlying causes of these strokes. The survey, conducted in summer 2015, polled 652 healthcare professionals including neurologists, cardiologists, hospitalists, primary care physicians and stroke coordinators.
October 29, 2015
News | Robotic Systems
Hansen Medical Inc. announced the shipment of the Magellan Robotic System to Holy Name Medical Center in Teaneck, New Jersey, the first hospital in the New York/New Jersey metropolitan area to purchase a system.
October 29, 2015
News | Information Technology
Critical advancements in modern technology will play an integral role in progressing the Future of Healthcare, according ...
October 29, 2015Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
SentreHeart Inc. announced that it has received CE Mark approval for the Lariat Surgical Left Atrial Appendage (LAA) Suture Delivery Device. The Lariat Surgical LAA device is a suture-based solution for soft tissue closure, including the LAA. European surgeons can now offer their patients precise, user-controlled delivery of a 50mm pre-tied suture loop through traditional open surgical procedures or through an access port as small as 5mm.
October 28, 2015
St. Jude Medical Inc. announced the company has received CE Mark approval for the HeartMate 3 Left Ventricular Assist System (LVAS). HeartMate 3 is a cardiac support option for advanced heart failure patients who are awaiting transplantation, are not candidates for heart transplantation or are in myocardial recovery.
October 28, 2015
Technology | Robotic Systems
Stereotaxis Inc. announced the worldwide launch of Respiratory Compensation, a new software feature of the company’s Niobe remote magnetic navigation system.
October 28, 2015© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now